WTX-214

N/A

Report date: 2023/01/14 21:32:29

Base Information

Drug NameWTX-214
Drug Alias NameWTX-214
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitors
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWestlake Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesWestlake Therapeutics
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A